In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus.
Acta Pharm Sin B
; 12(4): 1662-1670, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35847519
AUC, area under he curve; Antiviral; DENV, dengue virus; DMSO, dimethyl sulfoxide; Dengue virus; EB, erythrosin B; Erythrosin B; FDA, US Food and Drug Administration; FRET, fluorescence resonance energy transfer; Flavivirus; NS, non-structural protein; ORF, open reading frame; PFU, plaque-forming unit; PK, pharmacokinetic; PP, polyprotein precursor; Protease inhibitor; SAR, structure−activity relationship; SLC, split luciferase complementation; UTR, untranslated region; WHO, World Health Organization; ZIKV, Zika virus; Zika virus; aa, amino acid; dpi, day post infection; ip, intraperitoneal
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Países Bajos